好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2005 Annual Meeting | Epilepsy: Epidemiology and Antiepileptic Drug Therapy

Thursday 04/14/05
03:45 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Epilepsy, Epilepsy/Clinical Neurophysiology (EEG)
No CME available
Event Timeline
03:45 PM - 05:00 PM Abstract 001 - Long Term Outcomes of Children with a First Unprovoked Seizure
03:45 PM - 05:00 PM Abstract 002 - Differential and Dose Dependent Effects of In Utero Antiepileptic Drugs
03:45 PM - 05:00 PM Abstract 003 - Reliability of Self-Reported Seizures in Danish, Norwegian and Virginian Twins
03:45 PM - 05:00 PM Abstract 004 - Pharmacokinetics and Hormonal Effects of Lamotrigine-Combined Oral Contraceptive Co-Administration
03:45 PM - 05:00 PM Abstract 005 - Higher Incidence of Symptoms of Polycystic Ovary Syndrome in Women with Epilepsy Treated with Valproate Versus Lamotrigine
Faculty Disclosures
Ilo Leppik, MD Dr. Leppik has nothing to disclose.
W D. Shields, MD No disclosure on file
James D. Bowen, MD Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyers Squibb. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bowen has received research support from Biogen IDEC. The institution of Dr. Bowen has received research support from Genentech. The institution of Dr. Bowen has received research support from Genzyme. The institution of Dr. Bowen has received research support from Novartis. The institution of Dr. Bowen has received research support from Roche.
John C. Adair, MD No disclosure on file
No disclosure on file
Peiqing Qian, MD Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
Richard D. Heekin, MD No disclosure on file
Sita J. Sattaluri Dr. Sattaluri has nothing to disclose.
Chetan P. Gandhy, MD No disclosure on file
Guy A. Rouleau, MD, PhD, FAAN Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
David F. Black, MD No disclosure on file
Orlando G. Barsottini, MD, PhD Dr. Barsottini has nothing to disclose.
Elliot T. Dawson, MD Dr. Dawson has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Sonata Properites LLC. Dr. Dawson has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for 3438 Ash St LLC. Dr. Dawson has stock in Sonata Properites LLC. Dr. Dawson has stock in 816 16 1/2 St LLC. Dr. Dawson has stock in 3438 Ash St LLC.
Archana Hinduja, MD Dr. Hinduja has nothing to disclose.
Meghan E. Murphy, NP No disclosure on file
Julia H. Joo No disclosure on file
Jose Luiz Pedroso, MD Dr. Pedroso has nothing to disclose.
David Rezendes No disclosure on file
Boris Kandinov No disclosure on file
Rob Durcan, MB, BCh, BAO Dr. Durcan has nothing to disclose.